Search results
2024. 175 Years of Pfizer Breakthroughs. We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday.
- Careers
At Pfizer, you’ll lead your journey. Together, We Make...
- Products
Programs & Initiatives Pfizer's Multicultural Health Equity...
- Contact Us
Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192...
- Investors Overview
Pfizer Inc. - Investor Relations. Investor Relations. NYSE:...
- Newsroom
Pfizer is showcasing new research across the company’s key...
- Executives
Terramycin also marks the beginning of the Pfizer...
- Partners
Pfizer engages in flexible partnership models that includes...
- Updates and Statements
02.06.2024 Medicines Arvinas and Pfizer’s Vepdegestrant...
- About
Pfizer purchases a nearby vacant ice plant, and employees...
- Careers
News about Pfizer, lung cancer, Lorbrena
News about Pfizer, AstraZeneca, dividend stock
Also in the news
Pfizer Inc. (/ ˈ f aɪ z ər / FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Dec 11, 2020 · NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY ® (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years of age and older.
Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age whose ...
Sep 22, 2021 · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 years of age and older.